LFG
NUVB icon

Larson Financial Group’s Nuvation Bio NUVB Stock Holding History

Larson Financial Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159 Buy
+28
New +$137 ﹤0.01% 3619
2025
Q4 		– Sell
-5,400
Closed -$20K – 3605
2025
Q3 		$20K Hold
5,400
– – ﹤0.01% 1649
2025
Q2 		$10.5K Buy
5,400
+1,400
+35% +$2.92K ﹤0.01% 1787
2025
Q1 		$7.04K Hold
4,000
– – ﹤0.01% 1767
2024
Q4 		$10.6K Hold
4,000
– – ﹤0.01% 1460
2024
Q3 		$9.16K Buy
+4,000
New +$12.2K ﹤0.01% 1507

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Larson Financial Group's NUVB Position: Q2 2026 in Review

Larson Financial Group opened a new position in Nuvation Bio (NUVB) in Q2 2026: 28 shares worth $159. The stake represents ﹤0.01% of the portfolio and ranks #3619 among its holdings. This is a return to the name: Larson Financial Group previously reported a position in NUVB as recently as Q3 2025.

Larson Financial Group first reported a position in NUVB in Q3 2024 and has held it in 6 quarters since. The position peaked at $20K in Q3 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Larson Financial Group held 28 shares of Nuvation Bio worth $159 as of Q2 2026.
  • Nuvation Bio was a new Larson Financial Group position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3619 holding.
  • Larson Financial Group first reported a position in Nuvation Bio in Q3 2024 and has held it in 6 quarters since.
  • Larson Financial Group's Nuvation Bio position peaked at $20K in Q3 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.